CTLA4 and melanoma: Later in the same group, Alimohammadi et al. [11] combined chemotherapy (Doxil) and immunotherapy (anti-CTLA-4 antibody, free or PEGylated liposome-encapsulated) in treatment of well-established B16 mouse melanoma model.